CENTER FOR CLINICAL RESEARCH
ACTIVE-3 TICO Trial (NCT04501978)
Therapeutics for Inpatients with COVID-19
ALIVE Trial (NCT02931240)
Clinical Study of the BioVentrix Revivent System for Treatment of Left Ventricular Aneurysms (ALIVE)
ANTHEM-HFrEF Pivotal Study (NCT03425422)
DCM II TRIAL (NCT04476901)
The EXACT Trial (NCT04125732)
Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment
The Global cVAD Study (NCT04136392)
The Global cVAD Study will utilize observational data of the ABIOMED, Inc. hemodynamic support devices in real-world settings to drive best practice usage patterns identified through study analysis, to serve as a tool to measure and improve the quality of patient care, and also serve as a resource for future research and regulatory filings.
GORE EXCLUDER (NCT02489539)
Heart FID (NCT03037931)
Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency
The Houston HeartReach Registry is a community-wide registry research study that aims to make improvements in heart disease prevention, diagnosis, and treatment for all women to help identify trends in heart-health risks in a diverse population of women, develop future clinical trials, and recruit women for future research studies.
A clinical investigation to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
PERFORMANCE II Study (NCT04201132)
PORTICO IDE (NCT02000115)
The PORTICO clinical trial is a prospective, multi-center, randomized, controlled clinical study, designed to evaluate the safety and effectiveness of the Portico Transcatheter Heart Valve and Delivery Systems via transfemoral and alternative delivery methods.
Relieve HF (NCT03499236)
Stem Cell Therapy vs Standard of Care in Cardiomyopathy (NCT02962661)
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with Acute Respiratory Distress Syndrome Associated with COVID-19